High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6 11 16 18 L1 virus-like particle vaccine through 5 years of follow-up
Villa, L L, Costa, R L R, Petta, C A, Andrade, R P, Paavonen, J, Iversen, O-E, Olsson, S-E, Høye, J, Steinwall, M, Riis-Johannessen, G, Andersson-Ellstrom, A, Elfgren, K, Krogh, G von, Lehtinen, M, Malm, C, Tamms, G M, Giacoletti, K, Lupinacci, L, Railkar, R, Taddeo, F J, Bryan, J, Esser, M T, Sings, H L, Saah, A J, Barr, E
Published in British journal of cancer (04.12.2006)
Published in British journal of cancer (04.12.2006)
Get full text
Journal Article
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Villa, Luisa L, Costa, Ronaldo LR, Petta, Carlos A, Andrade, Rosires P, Ault, Kevin A, Giuliano, Anna R, Wheeler, Cosette M, Koutsky, Laura A, Malm, Christian, Lehtinen, Matti, Skjeldestad, Finn Egil, Olsson, Sven-Eric, Steinwall, Margareta, Brown, Darron R, Kurman, Robert J, Ronnett, Brigitte M, Stoler, Mark H, Ferenczy, Alex, Harper, Diane M, Tamms, Gretchen M, Yu, Jimmy, Lupinacci, Lisa, Railkar, Radha, Taddeo, Frank J, Jansen, Kathrin U, Esser, Mark T, Sings, Heather L, Saah, Alfred J, Barr, Eliav
Published in The lancet oncology (01.05.2005)
Published in The lancet oncology (01.05.2005)
Get full text
Journal Article
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Olsson, Sven-Eric, Villa, Luisa L, Costa, Ronaldo L.R, Petta, Carlos A, Andrade, Rosires P, Malm, Christian, Iversen, Ole-Erik, Høye, John, Steinwall, Margareta, Riis-Johannessen, Grete, Andersson-Ellstrom, Agneta, Elfgren, Kristina, von Krogh, Geo, Lehtinen, Matti, Paavonen, Jorma, Tamms, Gretchen M, Giacoletti, Katherine, Lupinacci, Lisa, Esser, Mark T, Vuocolo, Scott C, Saah, Alfred J, Barr, Eliav
Published in Vaccine (2007)
Published in Vaccine (2007)
Get full text
Journal Article
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/II/I6/I8 LI virus-like particle vaccine through 5 years of follow-up
VILLA, L. L, COSTA, R. L. R, ANDERSSON -ELLSTROM, A, ELFGREN, K, VON KROGH, G, LEHTINEN, M, MALM, C, TAMMS, G. M, GIACOLETTI, K, LUPINACCI, L, RAILKAR, R, TADDEO, F. J, PETTA, C. A, BRYAN, J, ESSER, M. T, SINGS, H. L, SAAH, A. J, BARR, E, ANDRADE, R. P, PAAVONEN, J, IVERSEN, O.-E, OLSSON, S.-E, HØYE, J, STEINWALL, M, RIIS-JOHANNESSEN, G
Published in British journal of cancer (2006)
Get full text
Published in British journal of cancer (2006)
Journal Article
Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: A 2-Year Randomized Controlled Clinical Trial
Poland, Gregory A., Jacobson, Robert M., Koutsky, Laura A., Tamms, Gretchen M., Railkar, Radha, Smith, Judith F., Bryan, Janine T., Cavanaugh, Paul F., Jansen, Kathrin U., Barr, Eliav
Published in Mayo Clinic proceedings (01.05.2005)
Published in Mayo Clinic proceedings (01.05.2005)
Get full text
Journal Article
A quadrivalent vaccine prevented persistent infection and disease associated with HPV types 6, 11, 16, and 18
Published in Evidence-based obstetrics and gynecology
(01.09.2005)
Get full text
Journal Article